Androtriol - Guangzhou Cellprotek Pharmaceutical

Drug Profile

Androtriol - Guangzhou Cellprotek Pharmaceutical

Alternative Names: YC-6

Latest Information Update: 13 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Guangzhou Cellprotek Pharmaceutical
  • Developer Guangzhou Cellprotek Pharmaceutical; Xiuhe Medical Technique
  • Class Anti-ischaemics; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Stroke

Most Recent Events

  • 13 Dec 2017 Chemical structure information added
  • 27 Jun 2017 Guangzhou Cellprotek Pharmaceutical has patent protection for androtriol in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top